GenMont Biotech Inc (3164) - Cash Flow Conversion Efficiency

Latest as of March 2026: 0.011x

Based on the latest financial reports, GenMont Biotech Inc (3164) has a cash flow conversion efficiency ratio of 0.011x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (NT$15.46 Million ≈ $487.07K USD) by net assets (NT$1.41 Billion ≈ $44.30 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see GenMont Biotech Inc stock valuation for the company's overall valuation and market capitalisation.

GenMont Biotech Inc - Cash Flow Conversion Efficiency Trend (2005–2025)

This chart illustrates how GenMont Biotech Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data.

GenMont Biotech Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of GenMont Biotech Inc ranked by their cash flow conversion efficiency. Explore 3164 cash flow quality index to measure how well operating cash flow supports reported net income.

Company	Cash Flow Conversion Efficiency
MeVis Medical Solutions AG XETRA:M3V	0.005x
OS Therapies Incorporated NYSE MKT:OSTX	-1.000x
Toplus Global Co Ltd TWO:3522	-0.092x
PanGen Biotech Inc KQ:222110	-0.122x
Histeel KO:071090	0.121x
Better Life Group Co Ltd TW:1805	0.002x
Oceanpal Inc NASDAQ:OP	-0.007x
Kinatico Ltd AU:KYP	0.084x

Annual Cash Flow Conversion Efficiency for GenMont Biotech Inc (2005–2025)

The table below shows the annual cash flow conversion efficiency of GenMont Biotech Inc from 2005 to 2025. View 3164 stock price and chart for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	NT$1.45 Billion ≈ $45.67 Million	NT$73.60 Million ≈ $2.32 Million	0.051x	-39.40%
2024-12-31	NT$1.48 Billion ≈ $46.62 Million	NT$123.95 Million ≈ $3.90 Million	0.084x	+250.84%
2023-12-31	NT$1.45 Billion ≈ $45.66 Million	NT$34.60 Million ≈ $1.09 Million	0.024x	-74.09%
2022-12-31	NT$1.50 Billion ≈ $47.17 Million	NT$137.95 Million ≈ $4.35 Million	0.092x	+25.79%
2021-12-31	NT$1.52 Billion ≈ $48.03 Million	NT$111.66 Million ≈ $3.52 Million	0.073x	-8.23%
2020-12-31	NT$1.48 Billion ≈ $46.69 Million	NT$118.27 Million ≈ $3.73 Million	0.080x	+55.11%
2019-12-31	NT$1.45 Billion ≈ $45.62 Million	NT$74.52 Million ≈ $2.35 Million	0.051x	+43.51%
2018-12-31	NT$1.56 Billion ≈ $49.23 Million	NT$56.03 Million ≈ $1.77 Million	0.036x	-36.63%
2017-12-31	NT$1.37 Billion ≈ $43.19 Million	NT$77.56 Million ≈ $2.44 Million	0.057x	+59.70%
2016-12-31	NT$1.28 Billion ≈ $40.32 Million	NT$45.34 Million ≈ $1.43 Million	0.035x	+1161.02%
2015-12-31	NT$1.50 Billion ≈ $47.27 Million	NT$-5.01 Million ≈ $-157.84K	-0.003x	+91.40%
2014-12-31	NT$1.60 Billion ≈ $50.32 Million	NT$-62.00 Million ≈ $-1.95 Million	-0.039x	-132.38%
2013-12-31	NT$837.28 Million ≈ $26.38 Million	NT$100.37 Million ≈ $3.16 Million	0.120x	+538.11%
2012-12-31	NT$861.62 Million ≈ $27.15 Million	NT$-23.58 Million ≈ $-742.77K	-0.027x	-161.99%
2011-12-31	NT$904.75 Million ≈ $28.50 Million	NT$39.94 Million ≈ $1.26 Million	0.044x	-83.72%
2010-12-31	NT$737.87 Million ≈ $23.25 Million	NT$200.03 Million ≈ $6.30 Million	0.271x	+58.78%
2009-12-31	NT$635.68 Million ≈ $20.03 Million	NT$108.53 Million ≈ $3.42 Million	0.171x	+3.44%
2008-12-31	NT$609.60 Million ≈ $19.21 Million	NT$100.62 Million ≈ $3.17 Million	0.165x	+99.72%
2007-12-31	NT$524.64 Million ≈ $16.53 Million	NT$43.36 Million ≈ $1.37 Million	0.083x	+29.07%
2006-12-31	NT$461.75 Million ≈ $14.55 Million	NT$29.56 Million ≈ $931.43K	0.064x	+94.99%
2005-12-31	NT$290.14 Million ≈ $9.14 Million	NT$9.53 Million ≈ $300.15K	0.033x	--

About GenMont Biotech Inc

TW:3164 Taiwan Biotechnology

Market Cap

$42.95 Million

NT$1.36 Billion TWD

Market Cap Rank

#22550 Global

#1385 in Taiwan

Share Price

NT$15.85

Change (1 day)

+0.96%

52-Week Range

NT$15.60 - NT$19.70

All Time High

NT$30.54